• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解2020年卡塔尔以初级医疗保健机构为基础的新冠病毒咽拭子采样人群的流行病学特征。

Understanding the epidemiological characteristics of the primary healthcare corporation-based COVID-19 swabbed persons in Qatar, 2020.

作者信息

Ali Abdulmalik Mariam, Al-Kuwari Mohamed Ghaith, Haj Bakri Ahmad, Ahmad Al Abdulla Samya, Chettiyam Kandy Mujeeb, Yousef Abdulla Maha, Michael Gibb John

机构信息

Primary Health Care Corporation, Doha, Qatar E-mail:

出版信息

Qatar Med J. 2022 Jul 11;2022(3):23. doi: 10.5339/qmj.2022.23. eCollection 2022.

DOI:10.5339/qmj.2022.23
PMID:35875402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9275378/
Abstract

BACKGROUND

In March 2020, Qatar started reporting increased numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19). National preventive measures were implemented, and a testing plan was developed to respond to the pandemic with the Primary Health Care Corporation (PHCC) as the central element. PHCC is the main public primary healthcare provider in Qatar and it operates in 27 health centers with around 1.4 million registered individuals as of January 1, 2020. The latter population was distributed across four main nationality groups; Middle Eastern and North African (51.5%), Asian (41.2%), African (2.4%), and others (5.1%). At the primary healthcare level in Qatar, this study describes the epidemiological characteristics of individuals registered at PHCC who had contracted COVID-19 in 2020 during the first wave before the vaccination phase and examines the factors associated with the positivity rate.

METHODS

Retrospective data analysis was conducted for persons screened for SARS-CoV-2 in primary healthcare health centers in Qatar between March 11 and December 31, 2020. The study analyzed the demographic characteristics of the tested persons and noncommunicable disease burden, positivity rate by month, nationality, and age-group, and the factors associated with the positivity rate.

RESULTS

Between March 11 and December 31, 2020, PHCC tested 379,247 persons for SARS-CoV-2, with a median age (IQR) of 32 (21-42) years. Of these, 57.0% were from the Middle East and North Africa, and 32.5% were originally from Asia. Overall, 10.9% had diabetes mellitus and 11.3% had hypertension. The epidemiological curve showed a steep increase in the positivity rate from March till May 2020, at the highest rate of 37.5% in May 2020. The highest positivity rate was observed among Asian males at 15.7%. The positivity rate was the lowest among the age-group aged 60 years and above. It was almost the same among the tested persons for SARS-CoV-2 in the three main age groups (0-18, 19-39, 40-59) at 10.1%, 12.3%, and 12.2%, respectively. In a multi regression model, being a male was associated with a higher risk (OR 1.15; 95% CI 1.13-1.17). Asians were at higher risk than those originally from the Middle East and North Africa (OR 1.29; 95% CI 1.27-1.32). COVID-19 infection was higher among those presenting clinical symptoms than asymptomatic individuals (OR. 4.52; 95% CI 4.42-4.64).

CONCLUSION

The epidemic among the PHCC-registered population predominantly affected younger ages and males, namely, coming from Asia. At the primary healthcare level, the COVID-19 infection rate was higher among those who presented with clinical symptoms. The lowest positivity rate among individuals >60 years may reflect the effectiveness of public health measures related to the high-risk group. Scaled-up testing at the primary healthcare level helped to detect more cases during the peak of the first wave and was reflected in a steady increase in the positivity rate flattened later due to the established public health measures.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/9275378/f2f621a30f5b/qmj-2022-023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/9275378/132282e1c055/qmj-2022-023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/9275378/f2f621a30f5b/qmj-2022-023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/9275378/132282e1c055/qmj-2022-023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/9275378/f2f621a30f5b/qmj-2022-023-g002.jpg
摘要

背景

2020年3月,卡塔尔开始报告严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染病例数增加,该病毒引发了2019冠状病毒病(COVID-19)。卡塔尔实施了国家预防措施,并制定了一项检测计划,以应对这场大流行,其中初级卫生保健公司(PHCC)是核心要素。PHCC是卡塔尔主要的公共初级卫生保健服务提供者,截至2020年1月1日,它在27个健康中心开展业务,登记在册的个人约有140万。这些人群分布在四个主要国籍群体中;中东和北非(51.5%)、亚洲(41.2%)、非洲(2.4%)和其他(5.1%)。在卡塔尔的初级卫生保健层面,本研究描述了在疫苗接种阶段之前的第一波疫情期间,2020年在PHCC登记感染COVID-19的个人的流行病学特征,并研究了与阳性率相关的因素。

方法

对2020年3月11日至12月31日期间在卡塔尔初级卫生保健健康中心接受SARS-CoV-2检测的人员进行回顾性数据分析。该研究分析了受测人员的人口统计学特征和非传染性疾病负担、按月、国籍和年龄组划分的阳性率,以及与阳性率相关的因素。

结果

在2020年3月11日至12月31日期间,PHCC对379247人进行了SARS-CoV-2检测,年龄中位数(IQR)为32(21 - 42)岁。其中,57.0%来自中东和北非,32.5%原籍亚洲。总体而言,10.9%的人患有糖尿病,11.3%的人患有高血压。流行病学曲线显示,从2020年3月到5月阳性率急剧上升,2020年5月达到最高,为37.5%。亚洲男性的阳性率最高,为15.7%。60岁及以上年龄组的阳性率最低。在三个主要年龄组(0 - 18岁、19 - 39岁、40 - 59岁)接受SARS-CoV-2检测的人员中,阳性率几乎相同,分别为10.1%、12.3%和12.2%。在多元回归模型中,男性与较高风险相关(OR 1.15;95% CI 1.13 - 1.17)。亚洲人比中东和北非原籍的人风险更高(OR 1.29;95% CI 1.27 - 1.32)。出现临床症状的人感染COVID-19的比例高于无症状个体(OR 4.52;95% CI 4.42 - 4.64)。

结论

在PHCC登记的人群中的疫情主要影响年轻人和男性,即来自亚洲的人群。在初级卫生保健层面,出现临床症状的人感染COVID-19的比例更高。60岁以上个体中最低的阳性率可能反映了针对高危群体的公共卫生措施的有效性。在初级卫生保健层面扩大检测有助于在第一波疫情高峰期间发现更多病例,并且由于已制定的公共卫生措施,阳性率随后稳步上升并趋于平稳。

相似文献

1
Understanding the epidemiological characteristics of the primary healthcare corporation-based COVID-19 swabbed persons in Qatar, 2020.了解2020年卡塔尔以初级医疗保健机构为基础的新冠病毒咽拭子采样人群的流行病学特征。
Qatar Med J. 2022 Jul 11;2022(3):23. doi: 10.5339/qmj.2022.23. eCollection 2022.
2
Epidemiology Characteristics of COVID-19 Infection Amongst Primary Health Care Workers in Qatar: March-October 2020.2020 年 3 月至 10 月卡塔尔初级保健工作者中 COVID-19 感染的流行病学特征。
Front Public Health. 2021 May 20;9:679254. doi: 10.3389/fpubh.2021.679254. eCollection 2021.
3
Epidemiological health assessment in primary healthcare in the State of Qatar- 2019.卡塔尔国2019年初级医疗保健中的流行病学健康评估
Qatar Med J. 2021 Oct 25;2021(3):57. doi: 10.5339/qmj.2021.57. eCollection 2021.
4
The impact of COVID-19 on primary health care services in Qatar: 2 years of response and coping 2020-2021.新冠疫情对卡塔尔初级卫生保健服务的影响:2020 - 2021年两年的应对与举措
J Family Med Prim Care. 2022 Dec;11(12):7743-7749. doi: 10.4103/jfmpc.jfmpc_1259_22. Epub 2023 Jan 17.
5
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.在卡塔尔感染 SARS-CoV-2 的德尔塔变异株和贝塔变异株患者的疾病严重程度。
JAMA Intern Med. 2022 Feb 1;182(2):197-205. doi: 10.1001/jamainternmed.2021.7949.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Antibiotics Prescriptions Pattern among Patients Visiting Primary Health Care Centers (PHCC) before and during COVID-19 Pandemic: A Cross-Sectional Population-Based Study from Qatar.新冠疫情之前及期间前往初级卫生保健中心(PHCC)就诊患者的抗生素处方模式:一项来自卡塔尔的基于人群的横断面研究
Antibiotics (Basel). 2023 Jul 25;12(8):1228. doi: 10.3390/antibiotics12081228.
8
Estimating point prevalence of COVID-19 in Qatar's primary care registered population: an RT-PCR drive-through study protocol.卡塔尔初级保健登记人群中新冠病毒病的点患病率估计:一项逆转录聚合酶链反应免下车检测研究方案
BJGP Open. 2021 Apr 26;5(2). doi: 10.3399/BJGPO.2020.0160. Print 2021 Apr.
9
Health risk factors, status and service utilisation of adults in primary health care settings in Qatar: The HEALTHSIGHT study protocol.卡塔尔初级卫生保健环境中成年人的健康风险因素、状况和服务利用情况:HEALTHSIGHT 研究方案。
PLoS One. 2024 May 29;19(5):e0304160. doi: 10.1371/journal.pone.0304160. eCollection 2024.
10
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.

引用本文的文献

1
Death by suicide during COVID-19 infection: Two case reports.新型冠状病毒肺炎感染期间自杀死亡:两例病例报告。
Qatar Med J. 2023 Jul 28;2023(1):12. doi: 10.5339/qmj.2023.12. eCollection 2023.

本文引用的文献

1
Epidemiological health assessment in primary healthcare in the State of Qatar- 2019.卡塔尔国2019年初级医疗保健中的流行病学健康评估
Qatar Med J. 2021 Oct 25;2021(3):57. doi: 10.5339/qmj.2021.57. eCollection 2021.
2
COVID-19 infection across workplace settings in Qatar: a comparison of COVID-19 positivity rates of screened workers from March 1st until July 31st, 2020.卡塔尔工作场所环境中的新型冠状病毒肺炎感染情况:2020年3月1日至7月31日期间接受筛查工人的新型冠状病毒肺炎阳性率比较
J Occup Med Toxicol. 2021 Jun 17;16:21. doi: 10.1186/s12995-021-00311-5. eCollection 2021.
3
Implementation of a drive-through testing clinic in Qatar for residents having recently returned from a country with a COVID-19 travel warning.
在卡塔尔为最近从有新冠病毒旅行警告国家返回的居民设立免下车检测诊所。
Qatar Med J. 2021 Feb 15;2020(3):42. doi: 10.5339/qmj.2020.42. eCollection 2020.
4
Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020.2020 年 2 月 28 日至 4 月 18 日,卡塔尔对 5685 例 SARS-CoV-2 感染病例的首次流行病学调查。
BMJ Open. 2020 Oct 7;10(10):e040428. doi: 10.1136/bmjopen-2020-040428.
5
High intensities of population movement were associated with high incidence of COVID-19 during the pandemic.人口流动强度大与大流行期间 COVID-19 的高发病率有关。
Epidemiol Infect. 2020 Aug 3;148:e177. doi: 10.1017/S0950268820001703.
6
Epidemiologic Characteristics, Transmission Chain, and Risk Factors of Severe Infection of COVID-19 in Tianjin, a Representative Municipality City of China.中国代表性直辖市天津市 COVID-19 严重感染的流行病学特征、传播链和危险因素。
Front Public Health. 2020 May 20;8:198. doi: 10.3389/fpubh.2020.00198. eCollection 2020.
7
Regulation and Trust: 3-Month Follow-up Study on COVID-19 Mortality in 25 European Countries.监管与信任:25 个欧洲国家 COVID-19 死亡率的 3 个月随访研究。
JMIR Public Health Surveill. 2020 Apr 24;6(2):e19218. doi: 10.2196/19218.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
10
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.